Among these kinds, inactivated vaccines and recombinant vaccines both stimulate human bodies to produce antiviral antibodies by immune stimulation through the target proteins of the virus; in the case of COVID-19, this is the S proteins [5]. This evidence concerns the gene PROS1 and COVID-19.